The U.S. Food and Drug Administration has issued a warning against Zofran (Ondansetron) use for treating morning sickness in pregnant women. Zofran was approved by the FDA to prevent nausea related to chemotherapy treatments in cancer patients. However, Zofran has been prescribed off-label to pregnant women to help treat morning sickness.
Zofran was not tested for use in pregnancy and preliminary studies reveal a link to Zofran and birth defects. Lawsuits claim that GlaxoSmithKline, Zofran’s drugmaker, knew there were dangers associated with Zofran for developing babies, yet continued to market its use to treat morning sickness.
According to lawsuits, birth defects linked to Zofran use are:
If you or a loved one sustained injuries due to a defective drug, unsafe drug lawyers may be able to help you obtain the justice you deserve. For more information, call (888) 444-8508.
This page has been written, edited, and reviewed by a team of legal writers following our comprehensive editorial guidelines. It was approved by attorney Doug Burnetti, founder of Burnetti, P.A., a board-certified civil trial lawyer with experience handling cases involving auto accidents, premises liability, medical malpractice, nursing home neglect, and product liability.
Understanding Nursing Home Abuse It’s tough to think about, but sometimes nursing homes — places meant for care and...
There’s something magical about the Fourth of July on the water—the warm sun, the sound of waves, the sparkle...
Understanding Road Trip Insurance Coverage Understanding your insurance coverage is essential when dealing with a road trip injury. Know...
If you or a loved one has been seriously injured, please fill out the form below for your free consultation or call us at 1-800-287-6388.
Message Us 
Call Us